Riluzole is a glutamate-modulating agent with neuroprotective properties approved for use in amyotrophic lateral sclerosis. The efficacy and safety of riluzole vs placebo as an adjunct to ...
In a randomized complete block design (RCBD), each level of a "treatment" appears once in each block, and each block contains all the treatments. The order of treatments is randomized separately for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback